Patents by Inventor Raju Mohan

Raju Mohan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NLRP3 MODULATORS
    Publication number: 20220259170
    Abstract: Described herein are NLRP3 modulators and methods of utilizing NLRP3 modulators in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: July 16, 2020
    Publication date: August 18, 2022
    Inventors: Raju MOHAN, John NUSS, Jason HARRIS, Shendong YUAN
  • HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
    Publication number: 20220227767
    Abstract: Described herein are heterocyclic compounds, compositions, and methods for their use for the treatment of disease.
    Type: Application
    Filed: March 18, 2022
    Publication date: July 21, 2022
    Inventors: Raju MOHAN, John NUSS, Jason HARRIS
  • ROR-GAMMA MODULATORS
    Publication number: 20220175765
    Abstract: Described herein are retinoic acid related-related orphan nuclear receptor (ROR) modulators and methods of utilizing ROR? modulators in the treatment of dermal diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: February 15, 2022
    Publication date: June 9, 2022
    Inventors: Raju MOHAN, John NUSS, Jason HARRIS
  • TYK2 PSEUDOKINASE LIGANDS
    Publication number: 20220169651
    Abstract: Described herein are TYK2 pseudokinase ligands and methods of utilizing TYK2 pseudokinase ligands in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: March 25, 2020
    Publication date: June 2, 2022
    Inventors: Raju MOHAN, John NUSS, Jason HARRIS, Shendong YUAN
  • TYK2 PSEUDOKINASE LIGANDS
    Publication number: 20220135567
    Abstract: Described herein are TYK2 pseudokinase ligands and methods of utilizing TYK2 pseudokinase ligands in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: February 7, 2020
    Publication date: May 5, 2022
    Inventors: Raju MOHAN, John NUSS, Jason HARRIS, Shendong YUAN
  • SPIROCYCLIC ROR-GAMMA MODULATORS
    Publication number: 20220106323
    Abstract: Described herein are retinoic acid related-related orphan nuclear receptor (ROR) modulators and methods of utilizing ROR-gamma modulators in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: December 15, 2021
    Publication date: April 7, 2022
    Inventors: Raju MOHAN, John NUSS, Jason HARRIS, Shendong YUAN
  • BICYCLIC ROR-GAMMA MODULATORS
    Publication number: 20220106329
    Abstract: Described herein are retinoic acid related-related orphan nuclear receptor (ROR) modulators and methods of utilizing ROR-gamma modulators in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: December 14, 2021
    Publication date: April 7, 2022
    Inventors: Raju MOHAN, John NUSS, Jason HARRIS, Shendong YUAN
  • LIVER X RECEPTOR (LXR) MODULATORS
    Publication number: 20220106274
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of LXR-associated diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: December 15, 2021
    Publication date: April 7, 2022
    Inventor: Raju MOHAN
  • Spirocyclic ROR-gamma modulators
    Patent number: 11242350
    Abstract: Described herein are retinoic acid related-related orphan nuclear receptor (ROR) modulators and methods of utilizing ROR-gamma modulators in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: February 8, 2022
    Assignee: ESCALIER BIOSCIENCES B.V.
    Inventors: Raju Mohan, John Nuss, Jason Harris, Shendong Yuan
  • Bicyclic ROR? modulators
    Patent number: 11230555
    Abstract: Described herein are retinoic acid related-related orphan nuclear receptor (ROR) modulators and methods of utilizing ROR-gamma modulators in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: January 25, 2022
    Assignee: ESCALIER BIOSCIENCES B.V.
    Inventors: Raju Mohan, John Nuss, Jason Harris, Shendong Yuan
  • JAK inhibitors
    Patent number: 11136329
    Abstract: Described herein are Janus kinase (JAK) inhibitors of Formula (I?): Also described herein are methods of utilizing JAK inhibitors of Formula (I?) in the treatment of diseases, disorders or conditions and pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: May 7, 2020
    Date of Patent: October 5, 2021
    Assignee: VIMALAN BIOSCIENCES, INC.
    Inventors: Raju Mohan, John Nuss, Jason Harris, Shendong Yuan
  • NLRP3 MODULATORS
    Publication number: 20210292336
    Abstract: Described herein are NLRP3 modulators and methods of utilizing NLRP3 modulators in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: March 15, 2021
    Publication date: September 23, 2021
    Inventors: Raju MOHAN, John NUSS, Jason HARRIS, Shendong YUAN
  • LIVER X RECEPTOR (LXR) MODULATORS
    Publication number: 20210269406
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of LXR-associated diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: May 7, 2021
    Publication date: September 2, 2021
    Inventor: Raju MOHAN
  • FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
    Publication number: 20210214362
    Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.
    Type: Application
    Filed: November 17, 2020
    Publication date: July 15, 2021
    Inventors: Raju Mohan, Benjamin Anthony Pratt
  • Liver X receptor (LXR) modulators
    Patent number: 11034657
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of LXR-associated diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: June 15, 2021
    Assignee: ELLORA THERAPEUTICS, INC.
    Inventor: Raju Mohan
  • Heterocyclic Compounds for the Treatment of Disease
    Publication number: 20210163485
    Abstract: Described herein are heterocyclic compounds, compositions, and methods for their use for treatment of disease.
    Type: Application
    Filed: May 16, 2018
    Publication date: June 3, 2021
    Inventors: Raju MOHAN, John NUSS, Jason HARRIS
  • FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
    Publication number: 20210147426
    Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.
    Type: Application
    Filed: September 18, 2020
    Publication date: May 20, 2021
    Inventors: Benjamin Anthony Pratt, Raju Mohan
  • FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE
    Publication number: 20210139490
    Abstract: Described herein are fused bicyclic compounds, compositions, and methods for their use for the treatment of disease.
    Type: Application
    Filed: September 17, 2020
    Publication date: May 13, 2021
    Inventors: Raju Mohan, Benjamin Anthony Pratt
  • TYK2 PSEUDOKINASE LIGANDS
    Publication number: 20210139486
    Abstract: Described herein are TYK2 pseudokinase ligands and methods of utilizing TYK2 pseudokinase ligands in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: November 5, 2020
    Publication date: May 13, 2021
    Inventors: Raju MOHAN, John NUSS, Jason HARRIS, Shendong YUAN
  • LIVER X RECEPTOR (LXR) MODULATORS FOR THE TREATMENT OF DERMAL DISEASES, DISORDERS AND CONDITIONS
    Publication number: 20210101895
    Abstract: Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of dermal diseases, disorders or conditions. Also described herein are pharmaceutical compositions containg such compounds.
    Type: Application
    Filed: May 13, 2020
    Publication date: April 8, 2021
    Inventor: Raju MOHAN